SCHEMBL31751902

SCHEMBL31751902

NC(=O)C1CC2(CC2)CN1c1ccc(C(F)(F)F)cn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.52
ABL1 P00519 1/20 0.52
LMNA P02545 1/20 0.52
ADAM10 O14672 1/20 0.47
MMP1 P03956 1/20 0.47
MMP2 P08253 1/20 0.47
MMP3 P08254 1/20 0.47
MMP7 P09237 1/20 0.47
MMP9 P14780 1/20 0.47
MMP8 P22894 1/20 0.47
MMP12 P39900 1/20 0.47
MMP14 P50281 1/20 0.47
ADAM17 P78536 1/20 0.47
ADAM9 Q13443 1/20 0.47
ADAM33 Q9BZ11 1/20 0.47
KMT2A Q03164 1/20 0.42
HSD11B1 P28845 8/20 0.41
HSD11B2 P80365 3/20 0.41
CNR2 P34972 4/20 0.40
CNR1 P21554 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31751895 0.89 ADAM10 (0.48) KDM4EABL1LMNAADAM10MMP1
SCHEMBL13015906 0.79 KDM4E (0.64) KDM4EABL1LMNAKMT2AHSD11B1
SCHEMBL29200952 0.76 KDM4E (0.60) KDM4EABL1LMNAKMT2AHSD11B1
SCHEMBL31751829 0.73 SCN10A (0.45) ADAM10MMP1MMP2MMP3MMP7
SCHEMBL31750971 0.73 SCN10A (0.45) ADAM10MMP1MMP2MMP3MMP7
SCHEMBL3773773 0.72 KDM4E (0.62) KDM4EABL1LMNAKMT2AHSD11B1
SCHEMBL31381191 0.70 KDM4E (0.76) KDM4EABL1LMNAKMT2AHSD11B1
SCHEMBL30540328 0.69 LMNA (1.00) KDM4EABL1LMNAKMT2AHSD11B1
SCHEMBL20458193 0.69 CNR2 (0.62) KDM4EABL1LMNAKMT2ACNR2
SCHEMBL4456801 0.68 SMN1; SMN2 (0.51) KDM4EABL1LMNAKMT2ACNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025264645-A1 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE LATIGO BIOTHERAPEUTICS, INC. (US) 2025-12-26 WO disclosed